Vanguard Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-221,371
| Closed | -$4.07M | – | 4361 |
|
2020
Q4 | $4.07M | Buy |
221,371
+5,115
| +2% | +$94K | ﹤0.01% | 3449 |
|
2020
Q3 | $3.97M | Sell |
216,256
-1,038
| -0.5% | -$19K | ﹤0.01% | 3268 |
|
2020
Q2 | $3.25M | Buy |
217,294
+6,685
| +3% | +$100K | ﹤0.01% | 3279 |
|
2020
Q1 | $3.33M | Buy |
210,609
+234
| +0.1% | +$3.7K | ﹤0.01% | 3148 |
|
2019
Q4 | $3.42M | Sell |
210,375
-2,042
| -1% | -$33.2K | ﹤0.01% | 3294 |
|
2019
Q3 | $3.16M | Buy |
212,417
+1,245
| +0.6% | +$18.5K | ﹤0.01% | 3287 |
|
2019
Q2 | $3.49M | Sell |
211,172
-3,461
| -2% | -$57.2K | ﹤0.01% | 3293 |
|
2019
Q1 | $3.71M | Buy |
214,633
+21,152
| +11% | +$366K | ﹤0.01% | 3247 |
|
2018
Q4 | $3.42M | Buy |
193,481
+9,653
| +5% | +$170K | ﹤0.01% | 3212 |
|
2018
Q3 | $3.34M | Buy |
183,828
+7,443
| +4% | +$135K | ﹤0.01% | 3369 |
|
2018
Q2 | $3.45M | Buy |
176,385
+34,352
| +24% | +$672K | ﹤0.01% | 3338 |
|
2018
Q1 | $2.49M | Buy |
142,033
+58,962
| +71% | +$1.03M | ﹤0.01% | 3383 |
|
2017
Q4 | $943K | Hold |
83,071
| – | – | ﹤0.01% | 3624 |
|
2017
Q3 | $885K | Sell |
83,071
-6,480
| -7% | -$69K | ﹤0.01% | 3617 |
|
2017
Q2 | $783K | Sell |
89,551
-30,059
| -25% | -$263K | ﹤0.01% | 3629 |
|
2017
Q1 | $1.41M | Buy |
119,610
+228
| +0.2% | +$2.69K | ﹤0.01% | 3488 |
|
2016
Q4 | $1.56M | Buy |
119,382
+10,359
| +10% | +$136K | ﹤0.01% | 3445 |
|
2016
Q3 | $1.58M | Buy |
109,023
+5,608
| +5% | +$81.3K | ﹤0.01% | 3460 |
|
2016
Q2 | $1.24M | Buy |
103,415
+1,541
| +2% | +$18.5K | ﹤0.01% | 3541 |
|
2016
Q1 | $1.9M | Buy |
101,874
+28,520
| +39% | +$532K | ﹤0.01% | 3401 |
|
2015
Q4 | $1.58M | Buy |
73,354
+12,978
| +21% | +$279K | ﹤0.01% | 3485 |
|
2015
Q3 | $1.02M | Buy |
60,376
+23,941
| +66% | +$405K | ﹤0.01% | 3624 |
|
2015
Q2 | $1.37M | Buy |
36,435
+27,824
| +323% | +$1.04M | ﹤0.01% | 3563 |
|
2015
Q1 | $271K | Buy |
+8,611
| New | +$271K | ﹤0.01% | 3949 |
|